Cancer incidence among male construction workers in Korea: a standardized incidence ratio analysis, 2009-2015.
Construction industry
Incidence
Neoplasm
Occupational groups
Journal
Epidemiology and health
ISSN: 2092-7193
Titre abrégé: Epidemiol Health
Pays: Korea (South)
ID NLM: 101519472
Informations de publication
Date de publication:
2023
2023
Historique:
received:
15
02
2023
accepted:
08
06
2023
medline:
14
8
2023
pubmed:
5
7
2023
entrez:
4
7
2023
Statut:
ppublish
Résumé
Construction workers face an elevated risk for several types of cancer. Nevertheless, there is a lack of large-scale epidemiological studies examining the risk of all cancers in construction workers. This study aimed to investigate the risk of various cancers in male construction workers using the Korean National Health Insurance Service (NHIS) database. We used data from the NHIS database from 2009 to 2015. Construction workers were identified using the Korean Standard Industrial Classification code. We calculated the age-standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) for cancer occurrence in male construction workers compared to all male workers. Compared to all male workers, the SIRs for esophageal cancer (SIR, 1.24; 95% CI, 1.07 to 1.42) and malignant neoplasms of the liver and intrahepatic bile ducts (SIR, 1.18; 95% CI, 1.13 to 1.24) were significantly higher in male construction workers. The SIRs for malignant neoplasms of the urinary tract (SIR, 1.19; 95% CI, 1.05 to 1.35) and non-Hodgkin lymphoma (SIR, 1.21; 95% CI, 1.02 to 1.43) were significantly elevated in building construction workers. The SIR for malignant neoplasms of the trachea, bronchus, and lung (SIR, 1.16; 95% CI, 1.03 to 1.29) was significantly higher in heavy and civil engineering workers. Male construction workers have an increased risk for esophageal cancer, liver cancer, lung cancer, and non- Hodgkin's cancer. Our results indicate that tailored strategies for cancer prevention should be developed for construction workers.
Identifiants
pubmed: 37402413
pii: epih.e2023060
doi: 10.4178/epih.e2023060
pmc: PMC10482566
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2023060Références
Ann Occup Environ Med. 2018 Nov 01;30:64
pubmed: 30410771
Occup Environ Med. 2018 Aug;75(8):593-603
pubmed: 29769352
Acta Oncol. 2009;48(5):646-790
pubmed: 19925375
Am Rev Respir Dis. 1980 May;121(5):887-92
pubmed: 7406323
Am J Ind Med. 1994 Oct;26(4):511-20
pubmed: 7810549
Eur J Cancer Prev. 2006 Oct;15(5):391-7
pubmed: 16912567
Occup Environ Med. 2009 Jan;66(1):23-31
pubmed: 18805886
Toxicol Sci. 2006 Sep;93(1):96-104
pubmed: 16740616
BMC Cancer. 2014 Jun 10;14:420
pubmed: 24917392
Int J Environ Res Public Health. 2022 Nov 29;19(23):
pubmed: 36498008
Lancet Planet Health. 2021 Sep;5(9):e633-e643
pubmed: 34450064
J Epidemiol. 2021 Dec 5;31(12):585-592
pubmed: 32801280
Int J Cancer. 2012 May 15;130(10):2397-406
pubmed: 21671472
Cancer Causes Control. 2005 Jun;16(5):599-607
pubmed: 15986116
Br J Cancer. 2012 Jun 19;107 Suppl 1:S92-S103
pubmed: 22710685
Inhal Toxicol. 2002 Apr;14(4):349-67
pubmed: 12028809
Int J Epidemiol. 2017 Apr 1;46(2):e15
pubmed: 26822938
Occup Environ Med. 2000 Apr;57(4):264-7
pubmed: 10810113
Scand J Work Environ Health. 1992 Feb;18(1):18-25
pubmed: 1313183
Indian J Occup Environ Med. 2017 Jan-Apr;21(1):2-8
pubmed: 29391741
Mol Oncol. 2021 Mar;15(3):753-763
pubmed: 33544948
BMC Public Health. 2015 Sep 22;15:941
pubmed: 26395169
Int J Cancer. 2010 Aug 1;127(3):578-88
pubmed: 19950227
Am J Epidemiol. 2009 Jan 15;169(2):176-85
pubmed: 19056833
Int J Epidemiol. 1993;22 Suppl 2:S29-35
pubmed: 8132389
Oxid Med Cell Longev. 2016;2016:7891574
pubmed: 27957239
Toxicol Appl Pharmacol. 2022 Feb 15;437:115891
pubmed: 35077758
Int J Epidemiol. 1995 Aug;24(4):750-7
pubmed: 8550272
Stat Med. 1994 Nov 15;13(21):2189-203
pubmed: 7846419
Int J Occup Environ Health. 2014 Apr-Jun;20(2):141-5
pubmed: 24999849
Environ Sci Pollut Res Int. 2022 Jan;29(3):4390-4400
pubmed: 34406566
BMC Cancer. 2014 Jun 06;14:406
pubmed: 24902960
J Thorac Oncol. 2010 Dec;5(12):2024-36
pubmed: 21155185
Sci Rep. 2020 May 25;10(1):8617
pubmed: 32451416
Anticancer Res. 2005 Jan-Feb;25(1B):425-8
pubmed: 15816606
Saf Health Work. 2016 Mar;7(1):63-71
pubmed: 27014493
Arch Toxicol. 2009 Oct;83(10):947-57
pubmed: 19543712
Int Arch Occup Environ Health. 2022 Apr;95(3):677-683
pubmed: 34654946
Br J Ind Med. 1988 Nov;45(11):777-81
pubmed: 2849478